Douglas AG
Douglas AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
01.05.2026 / 18:50 CET/CEST
Dissemination of a Voting Rights Announcement transmitted by
Receive updates from Biotech Investments for free, starting right now.
We can deliver them by email, via your phone or you can read them from a personalised news page on follow.it.
This way you won't miss any new article from Biotech Investments. Unsubscribe at any time.
Site title: Biotech Investments – Independent Medical Rating Agency for Biotech and Pharmaceutical Assets. Purpose-built for Investors and Industry Partners.
Is this your feed? Claim it!
Douglas AG
Douglas AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
01.05.2026 / 18:50 CET/CEST
Dissemination of a Voting Rights Announcement transmitted by
Douglas AG
/ Key word(s): Interim Report/Interim Report
DOUGLAS Group grows sales in Q2 and updates full-year guidance on adjusted EBITDA
30.04.2026 / 19:00 CET/CEST
The issuer is solely responsible for the content of this announcement.
Q2 2025/26 Trading Statement
DOUGLAS Group grows sales in Q2 and updates ful...
Basel, Switzerland. April 30th 2026, 19.00 CEST.
BioVersys AG (SIX: BIOV), a multi-asset, clin...
Gerresheimer AG
Gerresheimer AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
30.04.2026 / 18:41 CET/CEST
Dissemination of a Voting Rights Announcement transmitted by
Gerresheimer AG
Gerresheimer AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
30.04.2026 / 18:38 CET/CEST
Dissemination of a Voting Rights Announcement transmitted by